**vartis an**unces positive phase III results for MS drug siponimod
 

**vartis an**unces positive phase III results for MS drug siponimod

ZURICH (Reuters) – **vartis AG said a late-stage study showed its oral, once-daily BAF312, or siponimod, reduced the risk of disability progression in a severe form of multiple sclerosis.http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...W8:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...W8:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/I2UI9lOz3ME